Sustainability
Discover how MEGGLE combines pharmaceutical excellence with environmental and social responsibility – and how our actions today shape a healthier tomorrow.
High-quality lactose and co-processed Excipients
Excellence for your tablets, capsules and powder formulations
Welcome to MEGGLE – Your trusted partner in pharmaceutical lactose. With over 70 years of experience and a product portfolio unmatched in the industry, we have become a global leader in pharmaceutical excipients. Our deep expertise in direct compression, co-processing and dry powder inhalation empower our customers to achieve peak performance in their applications.
Supported by a global sales and distribution network and two production sites, we guarantee security of supply across 110 countries. Driven by our values as a family business, we deliver reliable and sustainable solutions that meet our customers’ expectations.
Partner with us and benefit from state of the art production technology, a world-wide team of application advisors and a strong research network.
70
Years of Experience
Lactose production since 1950
110
Countries are supplied
with high-quality Excipients
2
state-of-the-art production facilities
Located in Germany & USA
The world of lactose is our world.
Confidence built on quality – trusted by customers worldwide
Discover a product portfolio that combines quality, versatility, and pharmaceutical precision – for tablets, capsules, powder formulations, and inhalation applications. Find the ideal solution for your needs in just a few clicks – explore our full portfolio or use the product configurator to identify the right grade for your formulation!
Good to know
“At MEGGLE, innovation means more than developing excipients – it’s about transforming emerging trends and individual customer needs into reliable, high-performance solutions.”
Ricarda Leister, Head of R&D
Explore the world of MEGGLE
News & Expertise
-
MEGGLE Low Nitrite GradesMEGGLE low nitrite lactose grades – simplifying nitrosamine compliance with specified limit! MEGGLE Excipients is excited to introduce our latest premium lactose grades – ensuring maximum safety in pharmaceutical formulations: Looking for more information or a sample? Click on the product of your choice. Nitrite testing is not a pharmacopoeia requirement, however MEGGLE has developed a method using ion…
-
MEGGLE Excipients at CPHI 2025 in Frankfurt!Visit us at our booth 8.0P59 –October 28 to 30, 2025 We are excited to announce our participation at CPHI Frankfurt 2025, the premier trade show for the pharmaceutical industry! From October 28 to 30, 2025, we will showcase our high-quality pharmaceutical excipients and look forward to engaging in insightful discussions with you. Visit us…
-
Optimising the Aerodynamic Performance of Spray Dried mRNA Lipoplexes in Mannitol or Lactose MatrixOptimising the Aerodynamic Performance of Spray Dried mRNA Lipoplexes in Mannitol or Lactose Matrix. MEGGLE Excipients and the University of Kiel have joined forces to shed light on this interesting topic. Introduction: Many respiratory pathogens enter the body through the respiratory tract, the lungs and the mucosal immune system are promising targets for therapeutic interventions. Liquid vaccines…
-
MEGGLE Sustainability Report 2022/2023Care and determination The MEGGLE Group’s new Sustainability Report, which covers the reporting period 2022/2023, is now available online. The report provides a detailed overview of the current sustainability status of the MEGGLE Group as well as the company’s comprehensive sustainability strategy and associated fields of action. For the first time, all MEGGLE production sites…